South Africa’s Aspen profit rises, it plans Russia campaign

JOHANNESBURG (Reuters) – South Africa’s Aspen Pharmacare said on Wednesday its full-year earnings rose by a quarter, helped by strong performance at home and overseas, and it was planning a push into Russia. Aspen, Africa’s largest maker of generic drugs, said diluted headline earnings totalled 786.9 cents per share, up from 626.9 cents a year earlier. Headline earnings, the main measure of profit in South Africa, exclude certain one-time items. Revenue rose by 27 percent to 19.3 billion rand. …